Nanoparticles based on PLGA and its co-polymer: An overview
- 1 January 2009
- journal article
- review article
- Published by BRNSS Publication Hub in Asian Journal of Pharmaceutics
- Vol. 3 (4), 266
- https://doi.org/10.4103/0973-8398.59948
Abstract
Poly (D, L-lactide-co-glycolide) (PLGA) is approved by the Food and Drug Administration for drug delivery use. The polymeric nanoparticles based on PLGA and its co-polymer are designed for controlled and targeted drug delivery. Also, PLGA and its co-polymer are important in designing nanoparticles with desired characteristics such as biocompatibility, biodegradation, particle size, surface properties, drug release and targetability. This review focuses on the polymer literature, methods for preparation of nanoparticles and recent studies on the nanoparticles based on PLGA and its co-polymer for the conventional and targeted delivery of drugs by various routes.This publication has 4 references indexed in Scilit:
- Nanoparticle-Based Oral Drug Delivery System for an Injectable Antibiotic – StreptomycinChemotherapy, 2007
- Poly( d , l -Lactide-Coglycolide) Particles Containing Gentamicin: Pharmacokinetics and Pharmacodynamics in Brucella melitensis - Infected MiceAntimicrobial Agents and Chemotherapy, 2007
- Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2006
- Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1Polymer, 1979